Re: Limits of predictive models using microarray data for breast cancer clinical treatment outcome (multiple letters) [1]

Journal of the National Cancer Institute

Volumn 97, Issue 24, 2005, Pages 1851-1853

  Jansen, Maurice P H M ^a   Foekens, John A ^a   Klijn, Jan G M ^a   Berns, Els M J J ^a   Reid, James F ^b,c   Lusa, Lara ^b,c   De Cecco, Loris ^b,c   Coradini, Danila ^b   Veneroni, Silvia ^b   Daidone, Maria Grazia ^b   Gariboldi, Manuela ^b,c   Pierotti, Marco A ^b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HOX PROTEIN; INTERLEUKIN 17; TAMOXIFEN;

ACCURACY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CLINICAL FEATURE; COHORT ANALYSIS; DNA MICROARRAY; DNA SYNTHESIS; DRUG RESPONSE; EXON; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DNA PRIMERS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MICROARRAY ANALYSIS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, INTERLEUKIN; RESEARCH DESIGN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAMOXIFEN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 29844436176     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji433     Document Type: Letter

References (0)